Strain-dependent host transcriptional responses to toxoplasma infection are largely conserved in mammalian and avian hosts by Ong, YC et al.
Strain-Dependent Host Transcriptional Responses to
Toxoplasma Infection Are Largely Conserved in
Mammalian and Avian Hosts
Yi-Ching Ong1, Jon P. Boyle2, John C. Boothroyd1*
1 Stanford University, Department of Microbiology and Immunology, Stanford, California, United States of America, 2University of Pittsburgh, Department of Molecular
Biology, Pittsburgh, Pennsylvania, United States of America
Abstract
Toxoplasma gondii has a remarkable ability to infect an enormous variety of mammalian and avian species. Given this, it is
surprising that three strains (Types I/II/III) account for the majority of isolates from Europe/North America. The selective
pressures that have driven the emergence of these particular strains, however, remain enigmatic. We hypothesized that
strain selection might be partially driven by adaptation of strains for mammalian versus avian hosts. To test this, we examine
in vitro, strain-dependent host responses in fibroblasts of a representative avian host, the chicken (Gallus gallus). Using gene
expression profiling of infected chicken embryonic fibroblasts and pathway analysis to assess host response, we show here
that chicken cells respond with distinct transcriptional profiles upon infection with Type II versus III strains that are
reminiscent of profiles observed in mammalian cells. To identify the parasite drivers of these differences, chicken fibroblasts
were infected with individual F1 progeny of a Type II x III cross and host gene expression was assessed for each by
microarray. QTL mapping of transcriptional differences suggested, and deletion strains confirmed, that, as in mammalian
cells, the polymorphic rhoptry kinase ROP16 is the major driver of strain-specific responses. We originally hypothesized that
comparing avian versus mammalian host response might reveal an inversion in parasite strain-dependent phenotypes;
specifically, for polymorphic effectors like ROP16, we hypothesized that the allele with most activity in mammalian cells
might be less active in avian cells. Instead, we found that activity of ROP16 alleles appears to be conserved across host
species; moreover, additional parasite loci that were previously mapped for strain-specific effects on mammalian response
showed similar strain-specific effects in chicken cells. These results indicate that if different hosts select for different parasite
genotypes, the selection operates downstream of the signaling occurring during the beginning of the host’s immune
response.
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Introduction
The Apicomplexan parasite Toxoplasma gondii is unique among
known eukaryotic pathogens in its extraordinarily broad host
range. In vitro, it can infect virtually any eukaryotic cell; although
its only known definitive hosts are felines, Toxoplasma’s known
intermediate hosts include a wide range of warm-blooded
vertebrates around the world, from avians to mammals. As these
parasites are transmitted via carnivorism and ingestion of tissue
cysts from infected animals, these intermediate hosts represent an
important part of Toxoplasma’s life cycle.
To infect a given host productively, Toxoplasma must be able to
achieve the right balance with the host’s immune response. If the
response to infection is too weak and parasites are allowed to
proliferate unchecked, the infection will overwhelm the host; but if
the immune response to infection is too robust, it can lead to host
immunopathology. The importance of this balance has been
underscored by several studies examining the role of various host
immune factors in resistance to infection. In mice deficient in key
pro-inflammatory effectors such as IL-12, IFN-c, and p47 GTPases,
even mouse-avirulent strains of Toxoplasma cause a lethal infection
characterized by extremely high parasite burden and widespread
dissemination [1]. In the converse scenario, where mice are
deficient in key regulatory cytokines such as IL-10 and IL-27,
immunopathology resulting from infection is increased [2,3].
Toxoplasma has evolved a battery of strategies for the purpose of
modulating host immunity as reviewed elsewhere [4,5]. Interest-
ingly, the success of these strategies in murine hosts appears to vary
dramatically by parasite strain. Strain-dependence has been
observed for a range of phenotypes including blockade of host
apoptosis [6], evasion of p47 GTPase-mediated killing [7],
production of IL-12 [8], intersection of MAPK signaling [9],
induction of NF-kB signaling [10], and induction and sustenance
of JAK/STAT signaling [11]. It is therefore not surprising that
where specific parasite effectors underlying these phenotypes have
been identified and characterized, they are either highly
polymorphic between different parasite strains [11,12,13] and/or
differentially expressed between strains [9,14,15].
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Diversity among Toxoplasma strains is expected given the
diversity among its hosts. Strikingly, however, just three clonal
lineages – Type I, II, and III – account for the majority of clinical
and natural isolates in Europe and North America [16].
Moreover, genotypic analysis of these strains, as well as some of
the so-called ‘atypical’ strains that do not belong to one of these
three lineages (including a recently described Type IV/X lineage
found in North American animals [17,18]), has demonstrated that
there are generally only two major allelic types for each locus [19].
Consistent with this, a genealogy of the three major strains
suggests that the Type I and III strains are each descendants of a
cross between a Type II strain and one of two closely related
ancestral strains [20].
This raises the question of what kind of selective pressures might
have culminated in the emergence of especially the Types I and III
strains and driven selection for their particular polymorphic alleles.
For example, the Type I and III alleles encoding the secreted
rhoptry kinase ROP16 are suggested to play an important role in
dampening host inflammation by activation of human and murine
STAT3 and STAT6, an activity that may yield important benefits
for the parasite [21,22]. Yet the Type II allele has been maintained
and selected for, despite its apparently decreased activity vis-a`-vis
the STATs in human and murine cells resulting from a single
amino acid difference in the kinase domain [23]. Polymorphisms
in key parasite effectors likely reflect parasite adaptation for host
niches of particular importance in transmission [24]; however, the
nature of these host niches remains mysterious. One hypothesis is
that avian and mammalian hosts, being evolutionarily divergent
from each other, might represent two distinct and important host
niches and thereby partially explain the allelic dimorphism
observed in Toxoplasma strains. To return to the example of
ROP16, this hypothesis predicts that the polymorphism that
renders the Type II allele less active towards murine and human
STATs might actually promote its affinity for and activity towards
avian STATs, leading to a host-dependent inversion of the
observed phenotypic differences between strains.
Toxoplasma infects a broad range of avian species, from
passeriform birds like sparrows to domesticated birds like chickens
[25]. Very little is known, however, about the avian host response
to Toxoplasma infection, particularly how it varies by parasite
genotype. Some clues, however, come from studies of chickens
which may represent an important source of infection for humans
due to their ground-feeding habits that make them highly likely to
ingest parasite oocysts [26]. Generally, chickens are considered to
be refractory to severe Toxoplasma infection; in studies where
chickens were inoculated with high oocyst loads of either Type I or
Type II parasites, infection was confirmed by isolation of tissue
cysts, but no symptoms of disease were detected [27,28]. This is
strikingly different from the pattern observed in mice, where Type
I parasites have an LD100 of just one parasite. Outside of
experimental infections, neurological signs of toxoplasmosis have
been observed in chickens only in rare instances; the strains
isolated from these chickens were preliminarily genotyped as Type
II [29]. It is possible, however, that these strains might actually be
less common ‘atypical’ strains, as the few loci that were used for
the genotyping have been shown to yield less than complete
information [20].
We therefore set out to investigate whether and how avian host
response to Toxoplasma infection varies by parasite strain. We chose
to use chickens as a representative avian host for this study as they
are highly infected in nature [26]. Moreover, because of the
chicken’s importance to agriculture and as a model for vertebrate
development, a richer toolkit has been developed for their study
than is available for other avian species. Using transcriptomic
profiling of chicken embryonic fibroblasts and pathway analysis to
assess host response, we show here that chicken cells do indeed
respond with distinct host transcriptional profiles upon infection
with different strains. QTL analysis of these transcriptional
differences was used to map the parasite loci involved and the
results compared with previous studies in human fibroblasts. The
implications of the results for the evolution of Toxoplasma strain
differences are discussed.
Materials and Methods
Host cell culture and parasites
SL-29 primary chicken embryonic fibroblasts (CRL-1590;
ATCC, Manassas, VA) were maintained in Dulbecco’s modified
Eagle’s medium (30–2002; ATCC, Manassas, VA) supplemented
with 5% FCS (Hyclone, Logan, UT) and 5% tryptose phosphate
broth (Sigma, St. Louis, MO). Primary chicken embryonic
fibroblasts (CEFs) were derived from specific-pathogen-free
fertilized eggs purchased from Charles River (Wilmington, MA).
Fibroblasts were prepared from 12-day old embryos as described
elsewhere [30], and maintained in complete DMEM, comprised of
Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA)
supplemented with 10% heat-inactivated fetal calf serum (FCS;
Hyclone, Logan, UT), 2 mM L-glutamine, 100 U ml21 penicillin
and 100 mg ml21 streptomycin. For CEF maintenance, complete
DMEM was additionally supplemented with 1% heat-inactivated
chicken serum (Invitrogen, Carlsbad, CA), and 1 mM sodium
pyruvate (Invitrogen, Carlsbad, CA).
HFF (human foreskin fibroblasts [31]) were maintained in
complete DMEM as described previously [31]. Toxoplasma gondii
tachyzoites were maintained in vitro by serial passage on confluent
monolayers of HFF in complete DMEM at 37uC with 5% CO2, as
previously described [32]. The Type I RH and mutant RHDrop16
(‘‘ROP16-KO’’) strains have been described elsewhere [33]; the
Type II (ME49), Type III (CEP), and IIxIII F1 progeny have also
been described elsewhere [11]. F1 progeny used for this study
were: C96A5, C96B4, C96C12, C96E7, C96H6, STD3, STF3,
STG4, STC7, STC8, STD10, STE10, S2T, CL13, CL16, CL29,
S21, S23, S27, S28, and S30. Parasites were tested for
mycoplasma contamination at regular intervals and contamination
was not detected.
Microarray analysis
Parasites were harvested by syringe-lysis and washed twice in
35 ml complete DMEM, followed by filtration through a 5 mm
filter (Millipore, Billerica, MA) to remove cell debris. Confluent
monolayers of SL-29 or primary CEFs in 6-well plates were
infected at MOI ,3 and total RNA was extracted at the indicated
timepoint (5 or 24 hours post-infection) using Trizol (Invitrogen,
Carlsbad, CA). Total RNA from each sample was labeled using
either the Affymetrix One Cycle Labeling Kit or the Affymetrix 39
IVT Express Kit as indicated (Affymetrix, Santa Clara, CA). 20 mg
of resulting cRNA from each sample was hybridized onto
Affymetrix Chicken Genome Array chips. The microarray data
is MIAME compliant and the raw data has been deposited in the
NCBI Gene Expression Omnibus (GSE29565 http://www.ncbi.
nlm.nih.gov/geo/). Gene expression values were computed by
implementing the Robust Multichip Average procedure for
normalization [34]. Data were subjected to a two-class comparison
by Significance Analysis of Microarrays (SAM 2.0) analysis [35] as
implemented in MeV v. 4.6.1 from the TM4 software suite [36].
Genes meeting the threshold of a,5% false-discovery rate (FDR)
and absolute expression fold change greater than 1.5 were
considered as significantly differentially expressed. For the
Strain-Dependent Responses to Toxoplasma Infection
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genome-wide scan, R/QTL analysis was performed as described
previously [21,37]. To determine significance, p-values were
calculated based on 500 permutations; genes that mapped to a
parasite genetic locus with a p-value of ,0.05 were considered
significant.
Pathway analysis and functional annotation
Gene set enrichment analysis (GSEA) was used to find
candidate transcription factors and canonical pathways that were
activated or induced upon infection [38,39]. This program makes
use of defined gene sets that were generated experimentally,
computationally, or by curation of literature. It then allows for
comparison of ranked lists of genes to these reference sets and
determines whether members of these reference sets are randomly
distributed throughout the ranked lists (suggesting no overlap in
the biology of these sets) or primarily found at the top or bottom of
that list (suggesting enrichment). For the purposes of hypothesis-
generation, gene sets enriched with a false discovery rate (FDR)
,0.25 were considered significant. The following gene sets from
the Molecular Signatures Database were evaluated for enrich-
ment: c2.cgp.v3.0 (gene sets derived from literature where cells
were subjected to either chemical or genetic perturbations),
c2.kegg (gene sets derived from KEGG canonical pathway lists),
and c3.tft.v3.0 (gene sets predicted on the basis of a common cis-
regulatory motif conserved in the human, mouse, rat, and dog
genomes) [40]. Identification of functionally-related gene groups
Figure 1. Type II and Type III strains induce distinct transcriptional programs in chicken embryonic fibroblasts. Microarray analysis of
SL-29 chicken embryonic fibroblasts subjected to mock, Type II (ME49), or Type III (CEP) infection. 2 biological replicates were performed for each
treatment and RNA was harvested at 24 hours post-infection. Genes shown are those identified as significantly up-regulated by SAM analysis
(FDR,5% and fold change $1.5) either in Type III infection over Type II infection (A) or in Type II infection over Type III infection (B). For heatmap
representation, probe intensities were log2-transformed and median centered by row; unsupervised hierarchical clustering was then performed
(cluster numbers indicated on left). The color gradient key at top represents the color range in a log2 scale, from relative upregulation by 2-fold
(yellow) and relative downregulation by 2-fold (blue).
doi:10.1371/journal.pone.0026369.g001
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enriched in gene sets of interest was performed using DAVID 6.7,
available at http://david.abcc.ncifcrf.gov/[41,42].
Results
Type II strains and Type III strains induce distinct
transcriptional profiles in infected chicken embryonic
fibroblasts
Strain-dependent host response to the widespread Toxoplasma
strains Type II and Type III has been extensively characterized at the
transcriptional level in human foreskin fibroblasts [11,22] andmurine
macrophages [43]. To test the hypothesis that these strains might
elicit different host responses in avian cells, we infected SL-29 primary
chicken embryonic fibroblasts (SL-29s) with Type II and Type III
parasites and analyzed host gene expression 24 hours post-infection
by Affymetrix microarrays. Significance Analysis of Microarrays
(SAM) identified 432 genes that were significantly up-regulated
($1.5-fold-change and FDR,5%) in cells infected with Type III
versus Type II strains, and 450 genes that were significantly up-
regulated by the same criteria in Type II versus Type III infections
(Figure 1A and B). In some cases, both strains induced up-regulation
of gene expression relative to mock-infected cells (cluster 5 in Fig 1A,
cluster 1 in Fig. 1B), but the degree of up-regulation differed between
strains. In other cases, the directionality of the change in gene
expression relative to mock-infected cells was inverted depending on
the strain (cluster 4 in Fig. 1A, clusters 5 and 6 in 1B).
To investigate which signaling pathways might be implicated in
these strain-specific differences in expression profiles, we used
Gene Set Enrichment Analysis (GSEA), which identifies gene sets
that previous microarray experiments have reported to be
coordinately regulated by any of a large number of conditions.
Analysis of genes that were more highly expressed in the Type III-
infected cells vs. Type II infections revealed significant overlap
with gene sets associated with cell proliferation or oncogenic
transformation (Table 1), whereas analysis of genes more highly
expressed in Type II-infections identified gene sets up-regulated in
response to TNF-signaling, interferon-stimulation, and NF-kB-
stimulation (Table 2). Consistent with this, analysis using DAVID
software to identify enriched biological themes and functional
annotations showed that genes with higher expression in Type III-
infected cells vs. Type II-infections were enriched in functional
annotations for cellular adhesion, motility, proliferation, and JAK/
STAT signaling (Table 3), whereas genes with higher expression in
Type II-infected cells were enriched in functional associations with
leukocyte/lymphocyte regulation and apoptosis (Table 4).
To further dissect signaling pathways that were perturbed in a
strain-specific manner, we attempted to use GSEA to identify
transcription factor binding sites (TFBSs) enriched in genes
specifically up-regulated by either Type II or Type III infection.
The only TFBSs identified as significantly enriched (FDR,0.25)
in genes highly expressed during Type II infection were NF-kB
(FDR of 0.228) and PBX1 (FDR of 0.226) (Tables S1 and S2). No
TFBSs emerged as significantly enriched in genes highly expressed
during Type III infection. This lack of predictive ability for TFBSs
in an avian genome is not surprising given that GSEA makes use
Table 1. Gene sets from the Molecular Signatures Database
CGP (chemical and genetic perturbations) library identified by
GSEA as significantly enriched in Type III-induced genes.
NAME
FDR
q-val
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON 0.04
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN 0.05
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN 0.05
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN 0.06
BEIER_GLIOMA_STEM_CELL_UP 0.09
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP 0.10
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER 0.10
RICKMAN_HEAD_AND_NECK_CANCER_F 0.10
WANG_BARRETTS_ESOPHAGUS_UP 0.11
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP 0.15
GU_PDEF_TARGETS_DN 0.15
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN 0.15
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP 0.16
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP 0.17
LI_CISPLATIN_RESISTANCE_DN 0.21
RICKMAN_HEAD_AND_NECK_CANCER_E 0.22
HELLER_SILENCED_BY_METHYLATION_DN 0.22
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN 0.23
BROWNE_HCMV_INFECTION_18HR_DN 0.23
VALK_AML_WITH_FLT3_ITD 0.23
Gene sets with a false-discovery rate (FDR) q-val#0.25 were considered
significant and are listed here.
doi:10.1371/journal.pone.0026369.t001
Table 2. Gene sets from the Molecular Signatures Database
CGP (chemical and genetic perturbations) library identified by
GSEA as significantly enriched in Type II-induced genes.
NAME FDR q-val
SANA_TNF_SIGNALING_UP 0
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN 0.04
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN 0.04
HINATA_NFKB_TARGETS_KERATINOCYTE_UP 0.04
FARMER_BREAST_CANCER_CLUSTER_1 0.05
LINDSTEDT_DENDRITIC_CELL_MATURATION_A 0.05
HINATA_NFKB_TARGETS_FIBROBLAST_UP 0.07
DAZARD_RESPONSE_TO_UV_SCC_UP 0.07
TRAYNOR_RETT_SYNDROM_UP 0.08
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP 0.08
BROWNE_INTERFERON_RESPONSIVE_GENES 0.08
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS 0.09
DER_IFN_GAMMA_RESPONSE_UP 0.09
DUTTA_APOPTOSIS_VIA_NFKB 0.13
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP 0.13
ZUCCHI_METASTASIS_DN 0.13
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN 0.14
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN 0.14
GEISS_RESPONSE_TO_DSRNA_UP 0.15
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP 0.15
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN 0.15
LIANG_SILENCED_BY_METHYLATION_2 0.16
LINDSTEDT_DENDRITIC_CELL_MATURATION_B 0.25
Gene sets with a false-discovery rate (FDR) q-val#0.25 were considered
significant and are listed here.
doi:10.1371/journal.pone.0026369.t002
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of reference gene sets that are either predicted to be targets of
specific transcription factors based on bioinformatic analysis of
conserved motifs, or have been identified as transcription factor
targets based on experimental data. In both instances, the GSEA
TFBS reference gene sets were generated based on data from
select mammalian genomes, thus hindering direct comparison to
an avian context.
Overall, these results are reminiscent of the patterns observed
for Type II and Type III infection of murine macrophages [43]
and HFF [22]. As in the latter two cell lines, the gene signature
specific to Type II infection in chicken fibroblasts was found to be
significantly enriched in TFBSs for NF-kB. While direct
comparison of TFBSs enriched in the gene signature specific to
Type III infection of chicken cells vs. mammalian cells is not
possible for the reasons discussed above, functional annotation of
the Type III-specific signature in chicken fibroblasts bears a strong
resemblance to the Type III-specific signature in murine
macrophages, which is characterized by enrichment in TFBSs of
transcription factors involved in hematopoietic cell proliferation,
survival, and differentiation (GATA1, E2F and HOXA9) [43].
Genome-wide scan locates QTLs in the parasite genome
corresponding to strain-specific host gene expression
To further dissect the basis of the strain-specific transcriptional
profiles observed above, we set out to identify the parasite loci
involved using an approach that has previously revealed several
key parasite effectors operating in infection of human fibroblasts
[21]. This approach is based on the premise that if a host response
phenotype is strain-specifically regulated and has a basis in
parasite genotype, it should segregate among F1 progeny derived
from a cross between two strains that differ in that phenotype [11].
Accordingly, SL-29 chicken embryonic fibroblasts were infected
with 21 F1 progeny from a Type II x Type III cross and host gene
expression at 24 hours post-infection was profiled by microarray
as before. We then performed a genome-wide scan for association
of Toxoplasma genetic markers and the expression level of each of
the host genes represented on the microarray. Out of 32,773
chicken-specific probes, representing over 28,000 unique chicken
genes, 689 had LOD scores that mapped to a specific Toxoplasma
genomic locus with a significance level of p,0.05 (calculated by
permutation test; Fig. 2 and Table 5). Substantial clusters of host
genes (50 or more) mapped to chromosomes Ia, VIIa, VIIb, and
X. The presence of a peak on chromosome Ia was intriguing as it
is unusually monomorphic among the three major strains of
Toxoplasma; it has been suggested that it may carry an especially
important combination of monomorphic alleles that has facilitated
the extraordinary global sweep of these three clonal lineages [44].
This high level of conservation may facilitate future identification
of the relevant locus, as a search of ToxoDB v6.4 reveals just 24
predicted genes that contain non-synonymous SNPs between the
Type II and Type III genomes. Two of these predicted genes,
TGME49_094190 (encoding a protein with homology to 3-
hydroxyisobutyryl-CoA hydrolase) and TGME49_095380 (encod-
ing a protein with no known function and no apparent
homologues outside the Apicomplexa), contain a putative signal-
peptide and may be secreted into the host cell, making them
especially good candidates for modulating host cell response in a
strain-specific manner [45]. On VIIa, the majority of genes
mapped to the CS3 marker, which has previously been associated
with the polymorphic rhoptry kinase ROP18 [14,15]. On VIIb,
the majority of genes mapped in the vicinity of the L339 and
AK104 markers, which have been previously been associated with
the polymorphic rhoptry kinase ROP16 [21]. On chromosome X,
there were two distinct peaks; one is at the right end and indicates
Table 3. Functional categories identified by DAVID as
significantly enriched (FDR,25%) in Type III-induced genes.
Term FDR (%)
GO:0005576,extracellular region 0.0000033
gga04512:ECM-receptor interaction 0.0022
signal 0.0077
GO:0044421,extracellular region part 0.0089
signal peptide 0.042
gga04510:Focal adhesion 0.062
GO:0031012,extracellular matrix 0.18
glycoprotein 0.18
GO:0040008,regulation of growth 0.43
Secreted 0.38
GO:0009968,negative regulation of signal transduction 0.52
GO:0005578,proteinaceous extracellular matrix 0.50
GO:0010648,negative regulation of cell communication 0.70
GO:0045177,apical part of cell 0.56
GO:0007167,enzyme linked receptor protein signaling pathway 0.96
GO:0007155,cell adhesion 1.08
GO:0022610,biological adhesion 1.08
disulfide bond 0.96
IPR000980:SH2 motif 1.25
GO:0005887,integral to plasma membrane 1.11
glycosylation site:N-linked (GlcNAc…) 1.41
GO:0031226,intrinsic to plasma membrane 1.28
IPR001496:SOCS protein, C-terminal 1.94
SM00252:SH2 2.15
GO:0051240,positive regulation of multicellular organismal
process
3.28
SM00253:SOCS 2.58
GO:0006928,cell motion 4.63
disulfide bond 6.54
GO:0007169,transmembrane receptor protein tyrosine kinase
signaling pathway
8.40
GO:0001568,blood vessel development 8.84
GO:0007242,intracellular signaling cascade 10.62
GO:0001944,vasculature development 10.75
Signal transduction inhibitor 8.49
IPR013320:Concanavalin A-like lectin/glucanase, subgroup 9.92
GO:0031175,neuron projection development 11.93
GO:0051094,positive regulation of developmental process 12.34
GO:0030030,cell projection organization 13.48
Immunoglobulin domain 10.33
GO:0040014,regulation of multicellular organism growth 15.59
GO:0001525,angiogenesis 16.06
gga04630:Jak-STAT signaling pathway 10.60
GO:0048514,blood vessel morphogenesis 16.36
short sequence motif:Cell attachment site 13.94
IPR013098:Immunoglobulin I-set 14.57
GO:0005886,plasma membrane 13.72
IPR012680:Laminin G, subdomain 2 15.80
GO:0019838,growth factor binding 16.18
IPR001791:Laminin G 19.14
doi:10.1371/journal.pone.0026369.t003
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cosegregation with marker AK154 while the other is at the left and
is associated with AK66 and SRS4. AK154 has been previously
linked to a key polymorphic dense granule protein, GRA15, which
directs strain-specific NF-kB activation [22]. There is no known
candidate for a polymorphic locus in the region of AK66 and
SRS4 that has been shown to impact host gene expression,
although this peak falls in the vicinity of a previously-mapped locus
for virulence in mice [15].
Although the greatest number of host gene expression
differences were found to map significantly to a QTL on
chromosome VIIa (Table 5), comparison with the data summa-
rized in Fig. 1 revealed that many of these host genes were not
originally identified as substantially and significantly different in
expression levels between Type II and Type III infections. This
might be due to the threshold set for differential expression (fold-
change$1.5 and p,0.05) or a limitation in statistical power (n = 2
for both strains) in the original comparison that was overcome in
the comparison of multiple progeny strains; it is also possible that
epistatic interactions may have masked certain effects of the VIIa
locus. Of the genes that mapped to a given parasite locus in the
analysis of the F1 progeny and that were identified as significantly
different between infection with the Type II and Type III strains
(fold change $1.5), the majority mapped to chromosome VIIb
(Table 5). Functional annotation of the genes mapping to VIIb
revealed a significant enrichment of genes involved in tyrosine
kinase signaling cascades (SH2 motifs), JAK/STAT signaling
pathways, and extracellular matrix interactions (Table 6).
ROP16 is likely the key locus on chromosome VIIb
responsible for the differences in Type III vs. Type II
infection of CEFs
Because ROP16 was previously identified as the key QTL on
chromosome VIIb responsible for strain-specific host gene expres-
sion in HFFs, specifically STAT-dependent gene expression, we
Table 4. Functional categories identified by DAVID as
significantly enriched (FDR,25%) in Type II-induced genes.
Term FDR (%)
GO:0044421,extracellular region part 0.0016
GO:0005576,extracellular region 0.0027
GO:0051249,regulation of lymphocyte activation 0.016
GO:0002694,regulation of leukocyte activation 0.025
GO:0050865,regulation of cell activation 0.044
GO:0042981,regulation of apoptosis 0.093
GO:0043067,regulation of programmed cell death 0.11
GO:0010941,regulation of cell death 0.12
GO:0050863,regulation of T cell activation 0.12
GO:0005125,cytokine activity 0.12
GO:0006955,immune response 0.19
GO:0043068,positive regulation of programmed cell death 0.19
GO:0043065,positive regulation of apoptosis 0.19
GO:0010942,positive regulation of cell death 0.21
GO:0002250,adaptive immune response 0.21
GO:0002460,adaptive immune response based on somatic
recombination of immune receptors built from immunoglobulin
superfamily domains
0.21
GO:0045619,regulation of lymphocyte differentiation 0.65
GO:0051251,positive regulation of lymphocyte activation 0.73
GO:0005615,extracellular space 0.58
GO:0002696,positive regulation of leukocyte activation 0.93
GO:0002684,positive regulation of immune system process 0.97
GO:0042127,regulation of cell proliferation 0.97
GO:0050867,positive regulation of cell activation 1.17
GO:0019724,B cell mediated immunity 1.58
GO:0002449,lymphocyte mediated immunity 2.03
GO:0031012,extracellular matrix 2.69
GO:0002443,leukocyte mediated immunity 3.79
cytokine 3.24
GO:0043383,negative T cell selection 4.50
GO:0045060,negative thymic T cell selection 4.50
signal peptide 3.69
GO:0008285,negative regulation of cell proliferation 4.76
GO:0050870,positive regulation of T cell activation 5.14
GO:0000122,negative regulation of transcription from RNA
polymerase II promoter
5.33
GO:0045580,regulation of T cell differentiation 5.34
gga04514:Cell adhesion molecules (CAMs) 3.74
GO:0046649,lymphocyte activation 7.99
GO:0048048,embryonic eye morphogenesis 9.03
GO:0005578,proteinaceous extracellular matrix 6.78
GO:0030098,lymphocyte differentiation 9.60
GO:0042110,T cell activation 11.20
GO:0045061,thymic T cell selection 11.73
GO:0051250,negative regulation of lymphocyte activation 11.73
GO:0002695,negative regulation of leukocyte activation 11.73
signal 9.10
GO:0045321,leukocyte activation 13.40
GO:0009986,cell surface 10.01
GO:0002252,immune effector process 14.67
Term FDR (%)
Secreted 11.18
GO:0050866,negative regulation of cell activation 17.84
GO:0045089,positive regulation of innate immune response 17.84
GO:0007155,cell adhesion 20.73
GO:0022610,biological adhesion 20.73
GO:0045088,regulation of innate immune response 21.17
GO:0016064,immunoglobulin mediated immune response 21.17
GO:0002521,leukocyte differentiation 21.27
GO:0001775,cell activation 22.37
GO:0030217,T cell differentiation 22.77
GO:0005604,basement membrane 17.39
GO:0009897,external side of plasma membrane 17.72
GO:0016564,transcription repressor activity 20.13
GO:0045892,negative regulation of transcription, DNA-dependent 24.25
GO:0050778,positive regulation of immune response 24.56
GO:0045058,T cell selection 24.62
GO:0045596,negative regulation of cell differentiation 26.21
gga00982:Drug metabolism 17.83
gga00980:Metabolism of xenobiotics by cytochrome P450 17.83
doi:10.1371/journal.pone.0026369.t004
Table 4. Cont.
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asked whether ROP16 might again be responsible for the strain-
dependent differences in CEF gene expression that maps to this
chromosome. The Type I and Type III alleles of ROP16 are nearly
identical and have been shown to have similar activity and Type I
strains have been engineered that lack ROP16; hence, we could use
such a strain to characterize ROP16-dependent effects in chicken
cells. Primary chicken embryonic fibroblasts were infected with
either wild-type (WT) or Drop16 (ROP16-KO) Type I parasites at
MOI ,5 and RNA was harvested 5 hours post-infection for
microarray analysis. This timepoint differs from the 24 hour post-
infection timepoint used for analysis of strain-dependent differences,
but was chosen to facilitate comparison to previous studies of
ROP16-dependent transcriptional effects in human fibroblasts [33]
and murine macrophages [43]. We have found this timepoint to be
most useful when dissecting the effects of ROP16, since it has such a
rapid effect on STAT activation; for other parasite effectors that act
by other mechanisms, a later timepoint may be more useful in
revealing their effects on host cells, which is why the initial analysis
of strain-dependent differences was conducted at a 24 hour
timepoint. Based on SAM analysis, 43 probesets representing 37
unique host genes were identified as significantly up-regulated ($1.5
fold-change, p,0.05) inWT versus ROP16-KO parasites (Table 7).
This gene set had significant overlap with the genes identified as
mapping to Chromosome VIIb and those that were significantly
higher in Type III versus Type II infection (Table 7). Differences
between the two sets are expected as genes that are differentially
regulated in WT vs. ROP16-KO Type I parasites reflect a
dependence on ROP16 expression, but not necessarily in an
allele-specific manner (e.g., previous studies have shown that the
Type I, II and III alleles of ROP16 all drive the early activation of
STAT3/6 signaling; it is the sustained activation of these proteins
that differs between the Type I/III and Type II alleles [33,46].
Differences in the timepoint of analysis, as discussed above, might
also be expected to affect levels of gene expression. Other differences
between Type I and Type III strains, including minor differences in
the Type I vs. III alleles of ROP16, might also partially account for
the observed differences.
As an early activator of STAT3/6, ROP16 appears to
functionally mimic some of the effects of IL-4 signaling. Consistent
with this observation, a ROP16-dependent signature reminiscent of
IL-4 and JAK/STAT signaling was observed in CEFs. For instance,
the most differentially regulated chicken gene in comparisons of
infection with WT versus ROP16-KO Type I parasites or Type III
versus Type II parasites is CCL17 (Table 7). CCL17 is typically
elicited in response to IL-4 stimulation and is a Th2-attracting
cytokine produced by monocytes and that recruits CD4+/CD25+
regulatory T cells [47]. CXCR4, another gene that is highly
differentially expressed in the comparisons reported in Table 7, is
also characteristic of a Th2 environment and is known to be IL-4
responsive [48]. Taken together, these data suggest that the Type I/
III allele of ROP16 may have conserved function in chickens
relative to mammals and drive a Th2-like transcriptional program
similar to that seen in human fibroblasts and murine macrophages.
Figure 2. Genome-wide QTL map of strain-specific differences in host gene expression in infected chicken embryonic fibroblasts.
SL-29 chicken embryonic fibroblasts were infected with 21 F1 progeny from a Type II x Type III cross and host gene expression at 24 hours post-
infection was profiled by microarray. A one-dimensional genome-wide scan was conducted to identify Toxoplasma genetic markers associated with
the expression level of each of the host genes represented on the microarray. The output of this QTL analysis is graphed here, where each line
represents a host gene that mapped with a LOD score .2 to a Toxoplasma locus. To determine significance, p-values were calculated based on 500
permutations; genes that mapped to a parasite genetic locus with a p-value of ,0.05 were considered significant. Threshold LOD scores for this p-
value varied on a gene-by-gene basis from 2.10 to 3.14 and are represented by the two dotted gray lines overlaying the graph.
doi:10.1371/journal.pone.0026369.g002
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Discussion
We report here that, contrary to our original prediction, strain-
dependent differences in the response of CEFs to infection by
Type II and Type III strains exhibit broadly similar patterns to
those previously reported in murine macrophages and human
fibroblasts. Also consistent with previous findings, the polymorphic
rhoptry kinase ROP16 was identified as a key player, with the
enhanced activation of JAK/STAT pathways by the Type I/III
allele of ROP16, relative to the Type II allele, appearing to be
conserved in chicken cells. It is highly likely that, as in mammalian
cells, ROP16 is able to directly phosphorylate and activate STATs
in infected chicken cells. Direct confirmation of this awaits the
development of reagents suitable for study of chicken STATs. Of
note is that while chicken homologues of IL-4 and its cognate
receptor IL-4Ra have been identified [49], chickens lack an
identifiable homologue of STAT6 [50], which is the primary
mediator of IL-4 signaling in mammalian cells. Chickens do
possess a homologue of mammalian STAT5, however, and this
might mediate IL-4 signaling in chicken cells; IL-4 has been
known to signal through STAT5 as well as STAT6 in human and
murine cells [51] and STAT5 has been shown to respond to
hematopoietic cytokine signaling in chicken cells [52]. We and
others have observed that STAT5 activation in infected HFFs and
murine macrophages is ROP16-dependent (data not shown;
Jeroen Saeij, personal communication), providing a possible
molecular mechanism by which ROP16 might be able to effect
IL-4-like signaling in chicken cells.
Our results are not inconsistent with the hypothesis that the
selection for particular parasite strains has been driven by the
particular requirements of some special host (or hosts) that were
historically critical to the evolution of Toxoplasma. In initiating this
study, we looked to ROP16 as a paradigmatic parasite effector.
Studies in murine and human cells showed that in one allelic form,
it is capable of driving sustained activation of STAT3 and STAT6,
with dramatic consequences for host inflammation, whereas in
another allelic form, this activity is much reduced (although not
entirely ablated [21]). Given the consequences of ROP16’s activity
towards the STATs, we reasoned that potent activity should be a
universally beneficial one as far as parasite survival. We therefore
sought to identify a host in which the ‘inactive’ Type II allele
might prove to be actually more active towards the STATs than
Table 6. Functional categories identified by DAVID as significantly enriched (FDR,25%) in the set of genes mapping to
chromosome VIIb.
Term Fold Enrichment FDR (%)
IPR000980:SH2 motif 17.10 0.021
SM00252:SH2 14.28 0.031
IPR001496:SOCS protein, C-terminal 37.05 0.14
SM00253:SOCS 30.95 0.17
Signal transduction inhibitor 40.01 2.21
GO:0009968,negative regulation of signal transduction 10.18 8.62
GO:0005576,extracellular region 2.54 9.44
GO:0010648,negative regulation of cell communication 9.63 9.98
GO:0031175,neuron projection development 7.70 17.65
GO:0030182,neuron differentiation 5.15 18.26
GO:0005578,proteinaceous extracellular matrix 4.63 18.37
GO:0031012,extracellular matrix 4.38 21.63
domain:SOCS box 84.84 22.75
gga04910:Insulin signaling pathway 5.41 22.90
Secreted 2.94 23.19
gga04630:Jak-STAT signaling pathway 5.26 24.42
doi:10.1371/journal.pone.0026369.t006
Table 5. Genome-wide QTL mapping of strain-specific host
transcriptional response in chicken embryonic fibroblasts.
Number of genes mapping
Chromosome p,0.05
p,0.05 Type II vs. III
fold-change $1.5
Ia 115 2
Ib 1 0
II 10 0
III 14 4
IV 1 0
V 0 0
VI 0 0
VIIa 304 39
VIIb 137 98
VIII 22 1
IX 0 0
X 70 16
XI 9 0
XII 6 0
Expression values of each gene were treated as phenotypes and a one-
dimensional genome scan to detect major QTL associated with these
expression values was performed. For each gene, the parasite genomic locus
corresponding to the maximum LOD score was determined. p-values were
calculated by permutation test and only genes with maximum LOD scores
meeting the p,0.05 cutoff were considered significant.
doi:10.1371/journal.pone.0026369.t005
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the Type I/III allele. Since relative differences in STAT-activating
capability might be predicted to vary with molecular properties
such as substrate binding affinity, we hypothesized that a relevant
host context in which the substrate (in this case, the STATs) was as
molecularly divergent as possible from murine/human substrates
might represent the different niche we hypothesized. Toxoplasma
is known to naturally infect only warm-blooded animals, i.e.,
mammals and birds. Hence, in terms of a molecularly divergent,
intracellular context that might reasonably have been a factor in
the evolution of Toxoplasma (i.e., in a host with significant
transmission capability), avian cells represent an outer limit of
difference compared to the exclusively mammalian systems
previously studied. Chicken STATs have significant evolutionary
distance from mammalian STATs and share only ,90% amino
acid identity with murine STATs [53,54], leaving open the
possibility that their binding interaction with ROP16 might differ
in a potentially meaningful way. Our results, however, showed
that Type III strains still induce a JAK/STAT enriched gene
signature in CEF cells, indicating that the Type I/III allele of
ROP16 is still more active than the Type II allele in this different
host phylum.
Similarities to strain-specificity between chicken and murine
responses were also observed for other Toxoplasma QTLs. For
example, we observed a significant difference in the ability of Type
II vs. Type III strains to elicit a pro-inflammatory signature
enriched in NF-kB-regulated genes, just as has been reported for
infection of mammalian cells [22,43]. NF-kB is conserved in
chickens, with ,70% identity to mammalian NF-kB [55].
Recently, Rosowski and colleagues identified the secreted
polymorphic effector GRA15, located on chromosome X, that
drives Type II-induced NF-kB activation in murine and human
cells and accounts for this characteristic Type II-infection
signature [22]. Consistent with this, many genes that were highly
expressed in Type II vs. Type III infection of chicken fibroblasts
and are known to be typically induced by NF-kB (e.g. CD83,
HHIP, and CCL4) were found to map to chromosome X. Although
we have not proven that this difference is in fact due to GRA15,
this seems highly likely and suggests that for at least two major,
polymorphic effectors, ROP16 and GRA15, and in at least the cell
types so far examined, allele-dependent function is conserved in
both mammals and avians, despite significant differences in the
substrates with which they interact. These findings are consistent
with other reports showing that virulence factors may play
conserved roles across species and indeed, across kingdoms; this
has been strikingly demonstrated for Pseudomonas aeruginosa
virulence, which relies on the same genetic determinants in an
Arabidopsis leaf infiltration model and a mouse full-thickness skin
burn model [56].
It remains possible that we have simply not identified the
relevant host species of interest and that, in that host species, we
would indeed observe an inversion of ROP16’s strain-specific
phenotype vis-a`-vis the STATs and NF-kB. The available
evidence, however, is consistent with an alternative model of
strain selection wherein the Type II allele of ROP16 is weaker
with regard to STAT activation, across all host species. In this
scenario, the selection for the Type II allele would come from the
fact that inducing such strong and sustained activation of STATs
might not be beneficial to the parasite in all hosts. As previously,
STAT activation by ROP16 is associated with a driving of infected
cells towards a Th2 response [21,43]. It might be that in a host
already predisposed towards a Th2 response, additional suppres-
sion of inflammation may prove deleterious for the parasite. It is
known, for instance, that some laboratory strains of mice (e.g.
Balb/C) are Th2-inclined compared to others (e.g., C57Bl/6), in
part due to variations in MHC receptors and cytokine production
[57]; it might be the case that some important evolutionary host of
Toxoplasma in the wild, perhaps some rodent or avian species, is
already Th2-inclined. Hence, it might be to the parasite’s
advantage (i.e., transmission would be enhanced) if the infecting
strain of Toxoplasma did not further dampen inflammation by
Table 7. Comparison of genes significantly up-regulated by
Type I versus Type I Drop16 infection or Type III versus Type II
infection.
GENE SYMBOL
Fold Change,
I.I Drop16, 5 hpi
Fold Change,
III.II, 24 hpi
CCL17 21.2 399.6
CA2 8.2 25.7
--- 7.4
--- 4.1 16.2
CALCA 4.1
LOC424241 4.1
CXCR4 3.6
SOCS1 3.4 14.7
CISH 3.2 5.8
BMP2 3.1
DOK5 2.9 3.2
PPP1R3C 2.6 6.6
SERPINB2 2.6 6.2
EAF2 2.4 3.6
SOCS2 2.3 6.5
UGP2 2.2 3.6
RDH10 2.1 2.8
KRT14 2.1 2.9
NPTX2 2.0
--- 2.0 5.2
--- 1.9
--- 1.9
SOCS3 1.9 3.8
FST 1.9 4.6
CCL4 1.8
LOC395581 1.7
LOC422150 1.7
TNFRSF1B 1.6
WDFY2 1.6 4.6
PLK2 1.6
APPL2 1.6 3.2
SGK1 1.6
--- 1.6
--- 1.5 2.8
MEOX2 1.5 3.2
--- 1.5
SEMA3A 1.5 4.6
All genes identified as significantly up-regulated ($1.5 fold-change, p,0.05)
between chicken embryonic fibroblasts infected with Type I versus Type I
Drop16 parasites are shown here. Bold-face font indicates genes identified as
mapping to chromosome VIIb. Where more than one probe corresponded to a
given gene, the highest fold-change difference is shown.
doi:10.1371/journal.pone.0026369.t007
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strongly activating STAT3/6. Alternatively, the nature of other
infections that might co-exist with Toxoplasma in a given host
species might have demanded (i.e., selected) for a Toxoplasma strain
that pushes the immune response in a Th1 or Th2 direction. For
example, worm infections are associated with Th2 responses and
so whether a host species is generally infected with worms might
represent a significant variable in the optimal interaction of
Toxoplasma with that host.
The virulence and success of a pathogen such as Toxoplasma is
determined by both host and parasite factors. As such, a full
understanding of its pathogenesis and population biology must
take into account the possible interactions between these variables.
Toxoplasma affords a rich system for further exploration in this vein
as we learn more about polymorphic effectors such as ROP16 (the
parasite ‘variables’) and how these effectors modulate the outcome
of infection across the many different host contexts the parasite
encounters.
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